Nicholson John 4
4 · NEKTAR THERAPEUTICS · Filed Feb 2, 2018
Insider Transaction Report
Form 4
Nicholson John
SVP & Chief Financial Officer
Transactions
- Exercise/Conversion
Common Stock
2018-01-31$11.34/sh+120,000$1,360,800→ 392,536 total - Exercise/Conversion
Stock Option
2018-01-31−120,000→ 0 totalExercise: $11.34From: 2014-02-01Exp: 2018-02-01→ Common Stock (120,000 underlying)
Footnotes (1)
- [F1]This transaction was made for stock options scheduled to expire on February 1, 2018.